Morozova, Olena <br/><br/>
System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Sep 2010 
 - 4572-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-10-0627  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Aurora Kinase B<br/>Aurora Kinases<br/>Chromatography, Liquid--methods<br/>Drug Evaluation, Preclinical<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Neoplastic<br/>Gene Knockdown Techniques<br/>Humans<br/>Microarray Analysis<br/>Molecular Targeted Therapy--methods<br/>Neoplastic Stem Cells--metabolism<br/>Neuroblastoma--drug therapy<br/>Protein Kinase Inhibitors--therapeutic use<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>RNA, Small Interfering--pharmacology<br/>Systems Biology--methods<br/>Tandem Mass Spectrometry--methods<br/>Therapies, Investigational--methods<br/>Validation Studies as Topic